Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1994 Aug;72(2 Suppl):S40–S43. doi: 10.1136/hrt.72.2_suppl.s40

Pharmacokinetics of loop diuretics in congestive heart failure

D Craig Brater 1
PMCID: PMC1025573  PMID: 7946757

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander W. D., Branch R. A., Levine D. F., Hartog M. The urinary sodium: potassium ratio and response to diuretics in resistant oedema. Postgrad Med J. 1977 Mar;53(617):117–121. doi: 10.1136/pgmj.53.617.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andreasen F., Mikkelsen E. Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure. Eur J Clin Pharmacol. 1977 Aug 17;12(1):15–22. doi: 10.1007/BF00561400. [DOI] [PubMed] [Google Scholar]
  3. Benowitz N. L., Meister W. Pharmacokinetics in patients with cardiac failure. Clin Pharmacokinet. 1976 Nov-Dec;1(6):389–405. doi: 10.2165/00003088-197601060-00001. [DOI] [PubMed] [Google Scholar]
  4. Brater D. C., Chennavasin P., Seiwell R. Furosemide in patients with heart failure: shift in dose-response curves. Clin Pharmacol Ther. 1980 Aug;28(2):182–186. doi: 10.1038/clpt.1980.148. [DOI] [PubMed] [Google Scholar]
  5. Brater D. C., Day B., Burdette A., Anderson S. Bumetanide and furosemide in heart failure. Kidney Int. 1984 Aug;26(2):183–189. doi: 10.1038/ki.1984.153. [DOI] [PubMed] [Google Scholar]
  6. Brater D. C. Resistance to loop diuretics. Why it happens and what to do about it. Drugs. 1985 Nov;30(5):427–443. doi: 10.2165/00003495-198530050-00003. [DOI] [PubMed] [Google Scholar]
  7. Brater D. C., Seiwell R., Anderson S., Burdette A., Dehmer G. J., Chennavasin P. Absorption and disposition of furosemide in congestive heart failure. Kidney Int. 1982 Aug;22(2):171–176. doi: 10.1038/ki.1982.149. [DOI] [PubMed] [Google Scholar]
  8. Chaturvedi P. R., O'Donnell J. P., Nicholas J. M., Shoenthal D. R., Waters D. H., Gwilt P. R. Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure. Int J Clin Pharmacol Ther Toxicol. 1987 Mar;25(3):123–128. [PubMed] [Google Scholar]
  9. Ellison D. H. The physiologic basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med. 1991 May 15;114(10):886–894. doi: 10.7326/0003-4819-114-10-886. [DOI] [PubMed] [Google Scholar]
  10. Ellison D. H., Velázquez H., Wright F. S. Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest. 1989 Jan;83(1):113–126. doi: 10.1172/JCI113847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fredrick M. J., Pound D. C., Hall S. D., Brater D. C. Furosemide absorption in patients with cirrhosis. Clin Pharmacol Ther. 1991 Mar;49(3):241–247. doi: 10.1038/clpt.1991.23. [DOI] [PubMed] [Google Scholar]
  12. Greither A., Goldman S., Edelen J. S., Benet L. Z., Cohn K. Pharmacokinetics of furosemide in patients with congestive heart failure. Pharmacology. 1979;19(3):121–131. doi: 10.1159/000137299. [DOI] [PubMed] [Google Scholar]
  13. Kaissling B., Stanton B. A. Adaptation of distal tubule and collecting duct to increased sodium delivery. I. Ultrastructure. Am J Physiol. 1988 Dec;255(6 Pt 2):F1256–F1268. doi: 10.1152/ajprenal.1988.255.6.F1256. [DOI] [PubMed] [Google Scholar]
  14. Loon N. R., Wilcox C. S., Unwin R. J. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int. 1989 Oct;36(4):682–689. doi: 10.1038/ki.1989.246. [DOI] [PubMed] [Google Scholar]
  15. Nakahama H., Orita Y., Yamazaki M., Itoh S., Okuda T., Yamaji A., Miwa Y., Yanase M., Fukuhara Y., Kamada T. Pharmacokinetic and pharmacodynamic interactions between furosemide and hydrochlorothiazide in nephrotic patients. Nephron. 1988;49(3):223–227. doi: 10.1159/000185059. [DOI] [PubMed] [Google Scholar]
  16. Odlind B. O., Beermann B. Diuretic resistance: reduced bioavailability and effect of oral frusemide. Br Med J. 1980 Jun 28;280(6231):1577–1577. doi: 10.1136/bmj.280.6231.1577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Oster J. R., Epstein M., Smoller S. Combined therapy with thiazide-type and loop diuretic agents for resistant sodium retention. Ann Intern Med. 1983 Sep;99(3):405–406. doi: 10.7326/0003-4819-99-3-405. [DOI] [PubMed] [Google Scholar]
  18. Sigurd B., Olesen K. H., Wennevold A. The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide. Am Heart J. 1975 Feb;89(2):163–170. doi: 10.1016/0002-8703(75)90041-1. [DOI] [PubMed] [Google Scholar]
  19. Stanton B. A., Kaissling B. Adaptation of distal tubule and collecting duct to increased Na delivery. II. Na+ and K+ transport. Am J Physiol. 1988 Dec;255(6 Pt 2):F1269–F1275. doi: 10.1152/ajprenal.1988.255.6.F1269. [DOI] [PubMed] [Google Scholar]
  20. Vasko M. R., Cartwright D. B., Knochel J. P., Nixon J. V., Brater D. C. Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med. 1985 Mar;102(3):314–318. doi: 10.7326/0003-4819-102-3-314. [DOI] [PubMed] [Google Scholar]
  21. Wollam G. L., Tarazi R. C., Bravo E. L., Dustan H. P. Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am J Med. 1982 Jun;72(6):929–938. doi: 10.1016/0002-9343(82)90854-3. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES